Zhongze Announces Collaboration with Fudan Prof. Nashat Abumaria to Develop Novel AD Therapies
Zhongze Therapeutics and Prof. Abumaria to Develop Novel TRPM7 Ion Channel Modulators for Alzheimer's disease SHANGHAI, CHINA, March 8, 2022 /EINPresswire.com/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, …